Quarterly report pursuant to Section 13 or 15(d)

Significant Strategic Collaborations (Details Narrative)

v3.22.1
Significant Strategic Collaborations (Details Narrative) - USD ($)
 3 Months Ended 23 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Rcognized revenue $ 388,993 $ 191,216    
Revenue 388,993 191,216    
Research and development expenses 1,101,399 629,729    
Prepaid Expense and Other Assets, Current 732,368   $ 732,368 $ 479,399
Scripps Research [Member] | Scripps Agreement [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Research and development expenses     2,400,000  
Prepaid Expense and Other Assets, Current 200,000   $ 200,000 $ 200,000
Collaborative Agreements [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Rcognized revenue 0 0    
Royalty Revenue [Member] | Takeda [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue $ 400,000 $ 200,000